Shopping Cart
- Remove All
Your shopping cart is currently empty
Anti-B7-1 Antibody (3V341)
🥰Excellent
Catalog No. TMAY-03908
Anti-B7-1 Antibody (3V341) is a Rabbit antibody targeting B7-1. Anti-B7-1 Antibody (3V341) can be used in ELISA.
Anti-B7-1 Antibody (3V341)
Anti-B7-1 Antibody (3V341)
🥰Excellent
Catalog No. TMAY-03908
Anti-B7-1 Antibody (3V341) is a Rabbit antibody targeting B7-1. Anti-B7-1 Antibody (3V341) can be used in ELISA.
Product information is being updated, if you want to purchase, please click the bulk custom button.
Bulk & Custom
Questions
View MoreContact us for more batch information
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
| Description | Anti-B7-1 Antibody (3V341) is a Rabbit antibody targeting B7-1. Anti-B7-1 Antibody (3V341) can be used in ELISA. |
| Ig Type | Monoclonal Rabbit IgG |
| Clone | 3V341 |
| Reactivity | Cynomolgus, Rhesus |
| Application | ELISA |
| Recommended Dose | ELISA: 1:5000-1:10000 |
| Antibody Type | Monoclonal |
| Host Species | Rabbit |
| Construction | This antibody was obtained from a rabbit immunized with purified, recombinant Cynomolgus / Rhesus CD80 / B7-1 ( TMPY-04349; ; Met1-Asn242). |
| Purification | Protein A |
| Appearance | Liquid |
| Formulation | 0.2 μm filtered solution in PBS |
| Research Background | The B-lymphocyte activation antigen B7-1 (referred to as B7), also known as CD80, is a member of cell surface immunoglobulin superfamily and is expressed on the surface of antigen-presenting cells including activated B cells, macrophages and dendritic cells. As costimulatory ligands, B7-1 which exists predominantly as dimer and the related protein B7-2, interact with the costimulatory receptors CD28 and cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) expressed on T cells, and thus constitute one of the dominant pathways that regulate T cell activation and tolerance, cytokine production, and the generation of CTL. The B7/CD28/CTLA4 pathway has the ability to both positively and negatively regulate immune responses. CD80 is thus regarded as promising therapeutic targets for autoimmune diseases and various carcinomas.Cancer ImmunotherapyCo-inhibitory Immune Checkpoint TargetsImmune CheckpointImmune Checkpoint Detection: AntibodiesImmune Checkpoint Detection: ELISA AntibodiesImmune Checkpoint Detection: FCM AntibodiesImmune Checkpoint Detection: IHC AntibodiesImmune Checkpoint Detection: WB AntibodiesImmune Checkpoint ProteinsImmune Checkpoint TargetsImmunotherapyTargeted Therapy |
| Conjucates | Unconjugated |
| Immunogen | Recombinant Cynomolgus / Rhesus CD80 / B7-1 Protein (TMPY-04349) |
| Antigen Species | Cynomolgus, Rhesus |
| Biology Area | Cancer Drug Targets |
Stability & Storage
| Stability & Storage | Store at 2°C-8°C for 1 month. Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. Preservative-Free. |
| Transport | Shipping with blue ice. |
Sci Citations
Calculator
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . 
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy Anti-B7-1 Antibody (3V341) | purchase Anti-B7-1 Antibody (3V341) | Anti-B7-1 Antibody (3V341) cost | order Anti-B7-1 Antibody (3V341)
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.